Initial experience with aspirin use during robotic radical prostatectomy

Sepehr Nowfar, Ryan Kopp, Kerrin Palazzi-Churas, Ithaar H. Derweesh, Christopher J. Kane

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Background: New cardiology guidelines recommend antiplatelet therapy for some patients with cardiac stents. Aspirin use is relatively contraindicated during urologic surgery because of increased bleeding risk. We sought to review the outcomes of patients who continued aspirin during robot-assisted radical prostatectomy. Patients and Methods: Between October 2007 and February 2010, 249 patients underwent robot-assisted radical prostatectomy by a single surgeon. After consultation with the patients' cardiologists, 6 patients had coronary artery stents and continued aspirin perioperatively (Group 1), and 7 patients had coronary artery stents but did not continue aspirin perioperatively (Group 2). The remaining 236 patients had no coronary artery stents and did not require continued aspirin (Group 3). We analyzed our patients' preoperative characteristics, including age, prostate-specific antigen volume, and D'Amico risk, as well as operative time, blood loss, hematocrit changes, transfusion requirements, length of hospital stay, and complications. Results: We found no differences in operative time, estimated blood loss, changes in hematocrit, or length of hospital stay. No patients with any type of cardiac stent required a postoperative blood transfusion or had complications requiring more than simple anti-emetics, analgesics, or electrolyte correction. Nine patients in Group 3 required interventions for significant complications. Conclusion: Larger studies need to be performed to validate these observations.

Original languageEnglish (US)
Pages (from-to)225-229
Number of pages5
JournalJournal of Laparoendoscopic and Advanced Surgical Techniques
Volume22
Issue number3
DOIs
StatePublished - Apr 1 2012

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Initial experience with aspirin use during robotic radical prostatectomy'. Together they form a unique fingerprint.

  • Cite this